Agilon Health Lowers FY2026 Sales Guidance from $5.680B-$5.805B to $1.445B-$1.475B vs $5.719B Est
Agilon Health (NYSE: AGL ) lowers FY2026 sales outlook from $5.680 billion-$5.805 billion to $1.445 billion-$1.475 billion vs $5.719 billion estimate.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Agilon Health (NYSE: AGL ) lowers FY2026 sales outlook from $5.680 billion-$5.805 billion to $1.445 billion-$1.475 billion vs $5.719 billion estimate.